Non-steroidal anti-inflammatory drug-induced cardiovascular adverse events: a meta-analysis

罗非昔布 医学 塞来昔布 内科学 安慰剂 不利影响 冲程(发动机) 随机对照试验 心肌梗塞 危险系数 荟萃分析 药理学 置信区间 环氧合酶 工程类 病理 酶 化学 替代医学 机械工程 生物化学
作者
Bryan Gunter,Kristina Butler,Robert L. Wallace,Steven M. Smith,Sam Harirforoosh
出处
期刊:Journal of Clinical Pharmacy and Therapeutics [Wiley]
卷期号:42 (1): 27-38 被引量:137
标识
DOI:10.1111/jcpt.12484
摘要

What is known and objective Although non-steroidal anti-inflammatory drugs (NSAIDs) have been studied in randomized, controlled trials and meta-analyses in an effort to determine their cardiovascular (CV) risks, no consensus has been reached. These studies continue to raise questions, including whether cyclooxygenase-2 (COX-2) selectivity plays a role in conferring CV risk. We performed a meta-analysis of current literature to determine whether COX-2 selectivity leads to an increased CV risk. Methods We utilized randomized, controlled trials and prospective cohort studies. We selected eight NSAIDs based on popularity and COX selectivity and conducted a search of the MEDLINE, EMBASE, and Cochrane databases. Primary endpoints included any myocardial infarction (MI), any stroke, CV death, and a combination of all three (composite CV outcomes). Twenty-six studies were found that met inclusion and exclusion criteria. Comparisons were made between all included drugs, against placebo, and against non-selective NSAIDs (nsNSAIDs). Drugs were also compared against COX-2 selective inhibitors (COXIBs) with and without inclusion of rofecoxib. Results and discussion Incidence of MI was increased by rofecoxib in all comparison categories [all NSAIDs (OR: 1·811, 95% CI: 1·379–2·378), placebo (OR: 1·655: 95% CI: 1·029–2·661), nsNSAIDs (OR: 2·155, 95% CI: 1·146–4·053), and COXIBs (OR: 1·800, 95% CI: 1·217–2·662)], but was decreased by celecoxib and naproxen in the COXIB comparison [(OR: 0·583, 95% CI: 0·396–0·857) and (OR: 0·609, 95% CI: 0·375–0·989, respectively]. Incidence of stroke was increased by rofecoxib in comparisons with all NSAIDs and other COXIBs [(OR: 1·488, 95% CI: 1·027–2·155) and (OR: 1·933, 95% CI: 1·052–3·549), respectively]. Incidence of stroke was decreased by celecoxib when compared with all NSAIDs, nsNSAIDs, and COXIBs [(OR: 0·603, 95% CI: 0·410–0·887), (OR: 0·517, 95% CI: 0·287–0·929), and (OR: 0·509, 95% CI: 0·280–0·925), respectively]. No NSAID reached statistical significance in regard to CV death. Incidence of the composite endpoint was increased by rofecoxib when compared against all NSAIDs, placebo, and other COXIBs [(OR: 1·612, 95% CI: 1·313–1·981), (OR: 1·572, 95% CI: 1·123–2·201) and (OR: 1·838, 95% CI: 1·323–2·554), respectively]. Incidence of composite endpoint was decreased by celecoxib in the all NSAIDs and COXIBs comparisons [(OR: 0·805, 95% CI: 0·658–0·986) and (OR: 0·557, 95% CI: 0.404–0.767), respectively]. When rofecoxib was removed from the COXIBs group, no difference was found with any comparison, suggesting rofecoxib skewed the data. What is new and conclusion This instead of the meta-analysis suggests that COX-2 selectivity may not play a role in the CV risk of NSAIDs. Rofecoxib was the only drug to demonstrate harm and skewed the data of the COX-2 selective group.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
wjz完成签到,获得积分10
刚刚
1秒前
1秒前
Jing发布了新的文献求助10
1秒前
1秒前
whs发布了新的文献求助10
1秒前
rrr完成签到,获得积分10
1秒前
华仔的应助被豆奶粉或采纳,获得10
1秒前
小蘑菇的应助被一一采纳,获得10
2秒前
xiuuu发布了新的文献求助10
3秒前
Ari发布了新的文献求助10
3秒前
orixero的应助被OuyangShuo采纳,获得10
3秒前
3秒前
4秒前
酷波er的应助被zx采纳,获得10
5秒前
搜集达人的应助被AUK采纳,获得10
5秒前
6秒前
往不随发布了新的文献求助10
6秒前
WZJ发布了新的文献求助10
6秒前
6秒前
bronny完成签到,获得积分20
9秒前
JeanetteJin发布了新的文献求助10
9秒前
CipherSage的应助被勤恳的铲丝采纳,获得10
9秒前
在水一方的应助被succo采纳,获得10
9秒前
xxxg郭完成签到 ,获得积分10
10秒前
10秒前
琪琪发布了新的文献求助10
10秒前
11秒前
11秒前
赘婿的应助被ayzzdbr采纳,获得10
11秒前
cdercder的应助被而非哈随哈桑采纳,获得10
11秒前
Luuuuu的应助被而非哈随哈桑采纳,获得10
12秒前
传奇3的应助被而非哈随哈桑采纳,获得10
12秒前
大个的应助被而非哈随哈桑采纳,获得10
12秒前
丘比特的应助被而非哈随哈桑采纳,获得10
12秒前
12秒前
华仔的应助被1128采纳,获得10
13秒前
英俊的铭的应助被liurong采纳,获得10
13秒前
bronny发布了新的文献求助10
14秒前
14秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
plantTFDB 508
高分子基功能界面水蒸发材料与应用研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8177654
求助须知:如何正确求助?哪些是违规求助? 9568503
关于积分的说明 21799551
捐赠科研通 7772253
什么是DOI,文献DOI怎么找? 3432428
关于科研通互助平台的介绍 2556594
邀请新用户注册赠送积分活动 2478011